Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 14 of 23

Cannabis Science Negotiates Several Commercialization Deals To Make Its Anti-Cancer Cannabis Formulations Available To The Public

Created on 2018-06-11 19:17:17

Cannabis Science Announces Planned Thailand Business Partnership and Clinical Trials for Medical Marijuana

Created on 2018-06-11 19:16:16

Cannabis Science Contemplates Extending Shareholder Record Date While Providing Guidance And SEC Communications For Proposed Dividend to Shareholders of Record For A New Class of Common Shares

Created on 2018-06-11 19:06:36

Cannabis Science Provides Physician’s Documentation That Confirms Successful Treatment of Skin Cancer

Created on 2018-06-11 19:05:42

Cannabis Science Reports: National Cancer Institute Updates Confirm Successful Cancer Treatments with Medical Cannabis

Created on 2018-06-11 19:04:33

Cannabis Science Updates Cancer Patient Progress As It Receives Verbal Confirmation By A Physician That Both Sites Of The Former Lesions Are Free Of Cancer Cells; Official Physician Documentation To Follow

Created on 2018-06-11 19:03:37

Cannabis Science Initiates Preclinical Investigation of CS-TATI-1 for European Studies for Squamous/Basal Cell Carcinomas and Kaposi’s Sarcoma

Created on 2018-06-11 18:49:57

Cannabis Science and World AIDS Institute Announce Appointment of Dr. Robert Melamede to Scientific Advisory Board

Created on 2018-06-11 18:48:54

Cannabis Science is Encouraged by ASA's Challenge; the Appeals Court Hears Case on Rescheduling of the Case on the Medicinal Value of Cannabinoids

Created on 2018-06-11 18:47:37

Cannabis Science Appoints Christopher Meenan MS, MBA as Executive Vice President of Product Research and Development

Created on 2018-06-11 18:46:27

NBC News Reports History Being Made as Legalization For Colorado and Washington State Optimistically Impacts Growth For Cannabis Science's New Drug Development Programs and State-by-State Medicinal Initiatives

Created on 2018-06-11 18:45:25

Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call

Created on 2018-06-11 18:44:18

Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Science's Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma

Created on 2018-06-11 18:43:09

Cannabis Science, Inc. Appoints Harvard Law School Graduate Chad S. Johnson, Esq. as a Member of the Company's Board of Directors and as General Counsel

Created on 2018-06-11 18:41:59

Cannabis Science Appoints Dr. Michael J. Goldblatt, the Former Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA), to its Scientific Advisory Board

Created on 2018-06-11 18:40:54

Cannabis Science Announces Screening of 'American Drug War II,' Film by Kevin Booth, on Thursday, April 18

Created on 2018-06-11 18:33:59

Cannabis Science Announces Preclinical Development Program for CS-TATI-I, Commencing EU Operations in the Netherlands and Sourcing Proprietary Material for Pharmacokinetic Characterization

Created on 2018-06-11 18:32:48

Cannabis Science Appoints Clinical Development Expert, Dr. Dorothy Bray, as Chief Executive Officer (CEO) and Director, Focusing on CS-TATI-1 and Building Company's Drug Development Pipeline

Created on 2018-06-11 18:31:42

Cannabis Science Announces The Depository Trust Company (DTC) Lifts Share Trading "Chill" Effective Immediately

Created on 2018-06-11 18:30:37

Cannabis Science, Inc. (CBIS) Announces Submission of Cannabinoid-Based Patent Application N2010968 Titled 'Composition for the Treatment of Neurobehavioral Disorders'

Created on 2018-06-11 18:29:27

  • Start
  • Prev
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.